Kelonia Therapeutics

Eli Lilly in advanced talks to acquire Kelonia Therapeutics for over $2 billion, WSJ says

Eli Lilly is reportedly in advanced talks to acquire Kelonia Therapeutics for over $2 billion, per the Wall Street Journal. Reuters noted it could not immediately verify the report.